StoneX Group’s Fresh Tracks Therapeutics, Inc. Common Stock FRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-333
Closed -$1.89K 548
2022
Q2
$1.89K Buy
+333
New +$1.89K ﹤0.01% 501